Inactive Instrument

Highlights Sensidose AB

Equities

Navamedic ASA (OB:NAVA) completed the acquisition of Sensidose AB.	23-05-24	CI
EQL Pharma AB cancelled the acquisition of all the remaining stake in Sensidose AB.	23-05-16	CI
Sensidose AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
Sweden’s EQL Pharma Increases Bid for Sensidose	23-04-24	MT
Navamedic Raises Takeover Offer for Sensidose, Agrees to Buy 57% Stake	23-04-24	MT
EQL Pharma Launches SEK91 Million Takeover Bid for Sensidose	23-04-20	MT
EQL Pharma AB made an offer to acquire all the remaining stake in to acquire Sensidose AB for SEK 91.7 million.	23-04-19	CI
Navamedic ASA (OB:NAVA) made an offer to acquire Sensidose AB for SEK 96 million.	23-03-28	CI
Sensidose AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-16	CI
Sensidose AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-16	CI
Sensidose AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Sensidose Starts Trading on Sweden's Spotlight Stock Market	22-05-12	MT
Sensidose AB has completed an IPO in the amount of SEK 24.2355 million.	22-05-09	CI
BioStock: Sensidose ready for expansion and IPO	22-04-19	AQ
Sensidose AB has filed an IPO in the amount of SEK 24.2355 million.	22-04-11	CI

No results for this search